Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000226606Phase 4Not yet recruiting
Phase 4, open-label trial of propofol and sevoflurane (2 arms), sponsored by Austin Health. Primary endpoint: Change in ventilation-perfusion scatter indexed by d log SD. Planned start Feb 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000226606.